, Volume 11, Issue 6, pp 417-419
Date: 06 Nov 2009

Update on invasive opportunistic mycoses: Clinical trials review, 2008–2009

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Invasive fungal infections remain major causes for morbidity and mortality in severely ill or immunocompromised patients. The past decade saw major expansion in the antifungal armamentarium, and the precise role of newer antifungal agents continues to be defined through clinical trials. This article summarizes five of the most relevant clinical trials related to prevention and treatment of opportunistic fungal infections in adult patients published between 2008 and 2009.